본문 바로가기

Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
FEBS JOURNAL283(18) · pp.3438 · 2016
피인용
Web of Science 28
JCR IF
JCR 2015 4.237
ISSN
1742-464X

저자

  1. Ha, Danbee제1저자제주대학교, Coll Vet Med, KO
  2. Bing, So Jin제주대학교, Coll Vet Med, KO
  3. Ahn, Ginnae전남대학교, Dept Marine Biofood Sci, KO
  4. Kim, Jinhee제주대학교, Coll Vet Med, KO
  5. Cho, Jinhee제주대학교, Coll Vet Med, KO
  6. Kim, Areum제주대학교, Dept Adv Convergence Technol & Sci, KO
  7. Herath, Kalahe H. I. N. M.제주대학교, Coll Vet Med, KO
  8. 유학선부산대학교, 의과대학, 의과학과, 기생충학교실, KO
  9. Jo, Sangmee Ahn단국대학교, Coll Pharm, Dept Pharmacol, KO
  10. Cho, Ik-Hyun경희대학교, Inst Korean Med, Coll Korean Med, KO
  11. Jee, Youngheun교신저자제주대학교, Vet Med Res Inst, KO

초록

Experimental autoimmune encephalomyelitis (EAE) is an inflammatory disease in the murine central nervous system (CNS) and recapitulates the clinical and pathological features of human multiple sclerosis (MS). Glutamate carboxipeptidase II (GCPII), an enzyme expressed exclusively on astrocytes, is known to affect the disease progression of various neurological disorders by producing glutamate. Despite several findings indicating possible link between glutamate and MS/EAE, however, the involvement of astrocyte or GCPII on glutamate excitotoxicity has not received much attention in MS/EAE. When we examined GCPII expression during EAE progression in this study, we observed significantly elevated GCPII expression in peak stage of disease localized mainly in astrocytes. Intrigued by these results, we tried a potent GCPII inhibitor, 2-phosphonomethyl pentanedioic acid (2-PMPA), on EAE mice and noticed markedly attenuated EAE clinical signs along with significantly inhibited infiltration of inflammatory cells into CNS. Furthermore, 2-PMPA dampened the function of Th1 cell lineage and down-regulated mGluR1 expression in both periphery and CNS contributing to glutamate-mediated immune regulation. Our observations identify a sequence of events triggering EAE through GCPII overexpression, which may offer a novel therapeutic approach to the treatment of MS.

키워드

2-phosphonomethyl pentanedioic acidexperimental autoimmune encephalomyelitis (EAE)glutamate carboxypeptidase IIglutamate excitotoxicitymetabotropic glutamate receptorsNAAG PEPTIDASE INHIBITORST-CELL-ACTIVATIONMULTIPLE-SCLEROSISIN-VIVON-ACETYLASPARTYLGLUTAMATEDENDRITIC CELLSNERVOUS-SYSTEMRAT-BRAINRECEPTORSDAMAGE

식별자

WoS UID
000383701600011